On July 2, Willis Towers Watson rose 5.67% in regular trading, trading at approximately $276.33/share, with turnover of $77.72 million. The rally was driven by Goldman Sachs raising its price target on the stock from $295 to $316 while maintaining a Buy rating, coupled with broad-based strength across the insurance brokerage sector.

Goldman Sachs issued the upgraded target on July 1. According to FactSet data, the stock currently carries an average analyst rating of Overweight with a consensus price target of $333.55, suggesting significant upside from current levels. Other major firms maintaining positive outlooks include UBS (Buy, $374 target), Autonomous Research (Outperform, $369), and Keefe Bruyette & Woods (Outperform, $380).

Within the Insurance Brokers sector, the overall sector showed notable strength. Among individual stocks, Arthur J. Gallagher rose 6.2%, Brown & Brown rose 6.13%, Ryan Specialty rose 6.12%, Aon rose 4.54%, and Marsh rose 4.04%, reflecting significant sector-wide momentum.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)